YOLFTbeta
IRIDEX Corporation

IRIDEX Corporation

IRIX · NASDAQ · Healthcare / Medical Devices

0.69USD-0.02 (-2.75%)

Price History

Full chart

Market Stats

Previous Close0.7095
Open0.724
Day Range0.69 – 0.724
52-Week Range0.607 – 1.65
Volume5.74K
Market Cap10.89M
P/E (TTM)0.00
Forward P/E769.23
EPS-0.20
Dividend Yield0.00%
Beta0.63
50-Day Avg0.7716
200-Day Avg1.08

About

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat uncontrolled and refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Patrick Mercer
  • Employees93
  • Headquarters1212 Terra Bella Avenue, Mountain View, CA, United States, 94043, USA
  • Websitehttps://www.iridex.com

Leadership

  • Mr. Scott A. Shuda J.D.Executive Chairman · b. 1965
  • Mr. Patrick MercerCEO, President & Director · b. 1972
  • Mr. Romeo R. DizonChief Financial Officer · b. 1958
  • Mr. Bassem BouHabibSVP of International Sales & Business Development · b. 1976
  • Ms. Leigh SalvoHead of Investor Relations

Financials

Income Statement

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue8.80M12.40M18.10M23.60M26.76M33.44M27.27M30.63M31.70M32.81M37.03M35.90M55.53M48.53M43.21M43.69M33.16M33.86M38.27M42.81M41.76M46.16M41.59M42.60M43.45M36.35M53.90M56.97M51.87M48.67M52.67M
Growth (%)-+40.91%+45.97%+30.39%+13.40%+24.94%-18.43%+12.32%+3.48%+3.50%+12.86%-3.04%+54.67%-12.61%-10.95%+1.12%-24.11%+2.11%+13.04%+11.86%-2.47%+10.54%-9.89%+2.42%+1.99%-16.34%+48.30%+5.69%-8.96%-6.17%+8.23%
Cost of Revenue2.70M4.70M7.20M9.60M10.97M13.74M14.21M17.05M17.63M17.92M18.85M17.10M31.25M28.85M22.94M22.79M16.87M17.51M19.69M21.41M21.80M25.32M26.09M25.13M25.51M20.79M31.07M31.60M30.06M29.17M33.37M
Gross Profit6.10M7.70M10.90M14.00M15.79M19.69M13.07M13.59M14.07M14.89M18.18M18.80M24.28M19.68M20.27M20.90M16.29M16.35M18.59M21.41M19.95M20.84M15.50M17.47M17.94M15.56M22.83M25.37M21.81M19.50M19.31M
Gross Margin69.32%62.10%60.22%59.32%59.01%58.89%47.92%44.36%44.39%45.38%49.08%52.38%43.73%40.55%46.92%47.84%49.13%48.28%48.56%50.00%47.78%45.15%37.27%41.01%41.29%42.80%42.36%44.53%42.04%40.07%36.65%
Operating Expense4.70M6.70M8.20M12.20M13.97M16.91M15.06M13.77M14.12M15.96M16.37M23.57M48.40M27.21M17.75M18.11M14.36M17.21M15.95M18.82M19.66M23.40M28.39M30.34M26.91M22.14M30.36M32.91M31.81M27.80M21.88M
Operating Income1.40M1.00M2.70M1.80M1.82M2.79M-1.99M-181.00K-48.00K-1.08M1.81M-4.76M-24.11M-7.54M2.52M2.80M1.93M-860.00K2.63M2.59M288.00K-2.56M-12.89M-12.87M-8.97M-6.58M-7.53M-7.54M-10.01M-8.30M-2.57M
Operating Margin15.91%8.06%14.92%7.63%6.82%8.34%-7.29%-0.59%-0.15%-3.28%4.89%-13.27%-43.43%-15.53%5.83%6.40%5.83%-2.54%6.88%6.04%0.69%-5.56%-30.99%-30.21%-20.66%-18.11%-13.98%-13.24%-19.29%-17.06%-4.88%
EBITDA1.50M1.20M3.03M2.47M2.29M3.21M-1.13M688.00K655.00K-373.00K2.24M-3.49M-17.80M-3.52M3.42M4.11M2.85M267.00K3.12M3.01M810.00K-1.80M-12.17M-12.06M-8.29M-6.08M-6.73M-6.16M-7.45M-7.42M-2.83M
EBITDA Margin17.05%9.68%16.73%10.48%8.57%9.61%-4.14%2.25%2.07%-1.14%6.06%-9.72%-32.05%-7.24%7.91%9.41%8.59%0.79%8.16%7.02%1.94%-3.89%-29.26%-28.31%-19.07%-16.72%-12.49%-10.81%-14.36%-15.24%-5.38%
Net Income1.00M1.00M2.10M1.70M1.62M2.42M-1.27M150.00K371.00K-402.00K1.67M-5.75M-22.27M-7.37M2.58M3.05M2.61M1.44M2.23M10.04M474.00K-11.71M-12.87M-12.81M-8.81M-6.33M-5.22M-7.55M-9.57M-8.91M-4.44M
Net Income Margin11.36%8.06%11.60%7.20%6.05%7.23%-4.67%0.49%1.17%-1.23%4.51%-16.02%-40.11%-15.19%5.98%6.97%7.87%4.25%5.83%23.45%1.14%-25.38%-30.94%-30.08%-20.28%-17.41%-9.69%-13.25%-18.45%-18.31%-8.42%
R&D-1.30M1.70M3.10M3.92M5.26M4.81M4.32M4.03M4.51M4.20M5.51M5.78M4.01M3.61M3.81M3.91M4.38M3.68M4.63M5.21M5.37M5.73M4.01M3.68M3.28M6.87M7.17M6.83M5.45M3.67M
R&D as % of Total Revenue-10.48%9.39%13.14%14.67%15.75%17.63%14.09%12.72%13.74%11.33%15.35%10.41%8.26%8.35%8.73%11.80%12.95%9.63%10.81%12.49%11.62%13.78%9.40%8.47%9.03%12.74%12.59%13.17%11.20%6.96%
Interest Expense000000000000644.00K507.00K237.00K78.00K296.00K210.00K371.00K1.25M0000897.00K784.00K3.15M1.44M---
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.16%1.04%0.55%0.18%0.89%0.62%0.97%2.93%0.00%0.00%0.00%0.00%2.06%2.16%5.85%2.53%---

Balance Sheet

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets6.40M23.70M26.70M28.40M32.66M35.02M33.79M34.27M35.84M39.09M41.10M40.18M46.65M28.23M28.29M29.22M32.15M28.91M33.68M41.82M41.82M48.14M41.65M41.67M34.81M27.97M48.69M42.29M34.44M29.14M29.15M
Total Liabilities1.70M2.20M2.80M2.50M5.16M4.53M3.96M4.07M5.00M7.31M6.59M8.02M27.84M16.48M13.27M9.79M9.72M7.01M7.82M8.08M8.13M8.98M11.12M11.71M12.11M10.60M25.39M25.06M24.91M27.04M24.23M
Total Equity4.70M21.50M23.90M25.90M27.50M30.50M29.83M30.20M30.83M31.78M34.52M32.16M18.81M11.75M15.03M19.43M22.43M21.91M25.85M33.74M33.69M39.16M30.52M29.96M22.70M17.37M23.30M17.23M9.52M2.10M4.92M
Cash1.20M5.00M9.90M5.80M9.64M10.00M4.61M9.19M10.54M10.38M12.65M21.05M5.81M5.31M9.38M9.01M10.79M11.90M13.44M13.30M9.99M23.75M21.71M21.19M12.65M11.63M23.85M13.92M7.03M2.39M6.03M
Total Debt-10.00K----------9.88M6.00M3.52M---------3.21M4.19M2.66M1.77M2.75M4.64M4.53M
Net Debt-1.20M-4.99M-9.90M-5.80M-9.64M-10.00M-4.61M-9.19M-10.54M-10.38M-12.65M-21.05M4.07M693.00K-5.86M-9.01M-10.79M-11.90M-13.44M-13.30M-9.99M-23.75M-21.71M-21.19M-9.44M-7.44M-21.20M-12.15M-4.29M2.26M-1.50M

Cash Flow

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow900.00K-1.30M-100.00K-2.00M2.86M-74.00K-3.63M2.52M5.10M771.00K2.77M-1.39M-522.00K-96.00K6.80M3.48M3.05M-443.00K767.00K4.01M-593.00K-144.00K-3.56M-10.03M-7.91M-3.24M8.22M-9.52M-6.75M-7.29M-2.12M
Investing Cash Flow-200.00K-10.80M-4.40M-2.40M982.00K-133.00K-1.99M1.85M-4.00M-2.32M-1.46M8.23M-26.48M-223.00K-232.00K-418.00K-278.00K3.91M-253.00K-1.03M-1.30M-1.47M-782.00K-827.00K-509.00K-93.00K-5.56M-286.00K-109.00K-13.00K-143.00K
Financing Cash Flow-100.00K15.80M300.00K200.00K10.00K560.00K241.00K205.00K254.00K1.39M968.00K1.55M11.85M-79.00K-2.48M-3.43M-327.00K-2.39M1.03M-3.13M-1.42M15.36M2.31M10.38M-156.00K2.47M9.47M-73.00K-5.00K2.60M5.96M
Capital Expenditure200.00K600.00K1.80M800.00K591.00K652.00K491.00K284.00K603.00K386.00K340.00K515.00K947.00K223.00K232.00K193.00K203.00K394.00K380.00K568.00K875.00K1.06M575.00K440.00K128.00K97.00K213.00K286.00K109.00K13.00K143.00K
Free Cash Flow700.00K-1.90M-1.90M-2.80M2.27M-726.00K-4.13M2.23M4.50M385.00K2.43M-1.90M-1.47M-96.00K6.57M3.29M2.85M-837.00K387.00K3.45M-1.47M-1.21M-4.14M-10.46M-8.04M-3.33M8.00M-9.80M-6.85M-7.30M-2.26M
Dividends Paid----------------0000000--------
FCF to OCF77.78%146.15%1900.00%140.00%79.35%981.08%113.51%88.73%88.18%49.94%87.73%137.18%281.42%100.00%96.59%94.45%93.34%188.94%50.46%85.85%247.55%837.50%116.13%104.39%101.62%103.00%97.41%103.00%101.62%100.18%106.76%
Dividend Paid to FCF----------------0.00%0.00%0.00%0.00%0.00%0.00%0.00%--------

Earnings

Report DateApr 25, 1996Jul 23, 1996Oct 17, 1996Feb 10, 1997Apr 17, 1997Jul 17, 1997Oct 16, 1997Jan 29, 1998Apr 16, 1998Jul 23, 1998Oct 28, 1998Jan 28, 1999Apr 22, 1999Jul 22, 1999Oct 20, 1999Jan 28, 2000Apr 19, 2000Jul 19, 2000Oct 18, 2000Jan 30, 2001Apr 24, 2001Jul 25, 2001Oct 23, 2001Jan 30, 2002Apr 23, 2002Jun 30, 2002Sep 30, 2002Mar 31, 2003Jul 22, 2003Oct 21, 2003Feb 4, 2004May 4, 2004Jul 27, 2004Oct 19, 2004Feb 15, 2005Apr 29, 2005Aug 3, 2005Oct 25, 2005Feb 16, 2006May 15, 2006Aug 3, 2006Dec 26, 2006Apr 3, 2007Jul 9, 2007Nov 19, 2007May 13, 2008Aug 12, 2008Nov 4, 2008Mar 11, 2009May 15, 2009Aug 14, 2009Nov 13, 2009Mar 5, 2010May 7, 2010Aug 6, 2010Nov 5, 2010Mar 4, 2011May 6, 2011Aug 5, 2011Nov 4, 2011Mar 2, 2012May 4, 2012Aug 3, 2012Nov 2, 2012Feb 28, 2013May 2, 2013Aug 1, 2013Oct 31, 2013Feb 27, 2014May 1, 2014Jul 31, 2014Oct 30, 2014Mar 5, 2015May 7, 2015Aug 6, 2015Nov 5, 2015Mar 3, 2016May 5, 2016Aug 4, 2016Nov 3, 2016Mar 8, 2017May 3, 2017Aug 3, 2017Nov 2, 2017Mar 8, 2018May 3, 2018Aug 2, 2018Nov 1, 2018Mar 5, 2019May 2, 2019Aug 6, 2019Nov 7, 2019Mar 12, 2020May 11, 2020Aug 6, 2020Nov 9, 2020Mar 22, 2021May 11, 2021Aug 12, 2021Nov 11, 2021Mar 10, 2022May 12, 2022Aug 15, 2022Nov 10, 2022Mar 9, 2023May 11, 2023Aug 10, 2023Nov 14, 2023Mar 26, 2024May 14, 2024Aug 8, 2024Nov 12, 2024Mar 24, 2025Jun 18, 2025Aug 12, 2025Nov 11, 2025Mar 5, 2026May 19, 2026Aug 18, 2026Nov 10, 2026
EPS Estimate0.040.030.070.140.020.070.090.120.100.110.010.030.030.050.040.090.070.090.070.04-0.18-0.050.020.04-------0.040.040.030.06-0.010.030.050.070.020.050.030.04-0.02-0.16-0.01-0.04-0.04----------------0.020.030.040.040.040.060.040.02----0.040.050.01-0.03-0.12-0.12-0.12-0.15-0.27-0.33-0.32-0.28-0.24-0.24-0.22-0.19-0.15-0.19-0.22-0.17-0.10-0.14-0.15-0.14-0.11-0.16-0.15-0.14-0.11-0.12-0.11-0.12-0.05-0.12-0.12-0.09-0.05-0.12-0.09-0.06-0.02-0.07-0.01-
EPS Actual0.040.030.040.050.030.080.090.120.100.080.010.080.030.050.050.110.100.100.080.06-0.140.000.020.05-0.03-0.070.03-0.01-0.040.040.07-0.000.020.060.03-0.000.050.070.05-0.010.06-0.15-0.07-0.61-0.15-0.100.03-0.03-0.740.030.130.070.060.050.080.090.080.060.090.030.080.180.03-0.080.030.090.040.050.040.050.030.050.860.02-0.070.040.040.010.01-0.07-1.03-0.16-0.24-0.28-0.44-0.31-0.28-0.26-0.21-0.22-0.18-0.13-0.11-0.12-0.20-0.12-0.01-0.140.09-0.14-0.15-0.15-0.14-0.11-0.07-0.13-0.17-0.11-0.18-0.21-0.16-0.12-0.05-0.10-0.06-0.09-0.01-0.03-0.07-
Surprise0.00%0.00%-42.86%-64.29%50.00%14.29%0.00%0.00%0.00%-27.27%0.00%166.67%0.00%0.00%25.00%22.22%42.86%11.11%14.29%50.00%22.22%103.20%0.00%25.00%--------106.00%-50.00%100.00%-50.00%73.00%66.67%40.00%-28.57%-150.00%20.00%-600.00%-275.00%-2950.00%6.25%-900.00%175.00%25.00%----------------50.00%200.00%0.00%25.00%0.00%-16.67%-25.00%150.00%----0.00%-80.00%0.00%-133.33%-758.33%-33.33%-100.00%-86.67%-62.96%6.06%12.50%7.14%12.50%8.33%18.18%31.58%26.67%36.84%9.09%29.41%90.00%0.00%160.00%0.00%-36.36%6.25%6.67%21.43%36.36%-8.33%-54.55%8.33%-260.00%-75.00%-33.33%-33.33%-0.20%16.00%33.33%-50.00%46.50%57.14%-600.00%-
Timing-----------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours--------After-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-----------------After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hours-After-hours-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap10.89M
Enterprise Value16.50M
Trailing P/E0.00
Forward P/E769.23
PEG Ratio0.94
Price / Sales0.21
Price / Book331.20
EPS-0.20
Book Value-0.135
Revenue (TTM)51.57M
Gross Profit (TTM)18.53M
EBITDA-2.60M
Profit Margin-6.88%
Operating Margin-8.19%
Return on Equity-73.15%
Return on Assets-5.90%
Shares Outstanding17.56M
Shares Float5.21M
Beta0.63
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
19.46%
Insiders
36.82%
Retail / Other
43.72%

Top Institutional Holders

  • PARAGON Assoc & PARAGON Assoc II JV
    1.00M5.69%
  • Vanguard Capital Management, LLC
    514.59K2.93%
  • Renaissance Technologies Corp
    396.63K2.26%
  • Weber Capital Management LLC
    180.45K1.03%
  • Geode Capital Management, LLC
    160.16K0.91%
  • Citadel Advisors Llc
    98.95K0.56%
  • Vanguard Fiduciary Trust Co
    60.16K0.34%
  • United Capital Financial Advisers Inc
    57.53K0.33%
  • Perkins Capital Management Inc
    55.30K0.31%
  • State Street Corp
    44.72K0.25%
  • Jane Street Group LLC
    37.63K0.21%
  • The Goldman Sachs Group Inc
    37.62K0.21%
  • DIVERSIFY WEALTH MANAGEMENT, LLC
    33.84K0.19%
  • Susquehanna International Group, LLP
    28.92K0.16%
  • Bank of New York Mellon Corp
    25.65K0.15%
  • Northern Trust Corp
    21.31K0.12%
  • BlackRock Inc
    20.26K0.12%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    401.85K2.29%
  • Fidelity Extended Market Index
    72.57K0.41%
  • Fidelity Series Total Market Index
    16.87K0.10%